Atara Biotherapeutics (ATRA) Financials

$9.42

$-0.47 (-4.75%)

As on 11-Sep-2026 11:26EDT

Market cap

$98 Mln

Revenue (TTM)

$6 Mln

P/E Ratio

--

P/B Ratio

16.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	6.19	120.77	128.94	8.57	63.57	20.34
Cost of Revenue	0.53	21.21	21.01	8.89	269.99	11.38
Gross Profit	5.66	99.56	107.93	-0.31	-206.42	20.34
Operating Expenses	19.89	63.70	191.37	275.69	74.10	360.80
Operating Profit (EBIT)	-14.23	35.86	-83.44	-276.01	-280.51	-340.46
Other Income	--	--	--	--	52.22	0.37
Profit before Tax	-16.66	32.72	-85.42	-276.11	-228.29	-340.10
Provision for Tax	0.03	0.03	-0.01	0.02	0.01	0.05
Profit after Tax (Net Income)	-16.69	32.69	-85.40	-276.13	-228.30	-340.14
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-228.30	-340.14

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	-37.00	-38.50	-97.28	-99.23	126.64	279.61
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	51.17	43.82	71.81	122.51	170.86	82.73
Current Liabilities	6.85	14.92	134.57	142.23	78.92	105.79
Total Liabilities	27.87	20.24	109.10	165.50	376.42	468.13

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	7.49	8.02	44.20	63.64	81.34	83.51
Current Assets	13.53	12.21	64.89	101.87	295.08	384.62
Total Assets	27.87	20.24	109.10	165.50	376.42	468.13
Total Debt*	9.88	52.80	43.83	57.87	71.70	28.27
Net Current Assets	6.68	-2.71	-69.68	-40.36	216.16	278.84

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-50.94	-68.72	-192.98	-270.43	-220.52
Cash Flow from Investing Activities	--	18.15	8.62	123.87	202.96	22.26
Cash from Financing Activities	--	16.10	59.28	2.01	53.08	103.94
Net Cash Inflow / Outflow	--	--	--	--	-14.39	-94.32

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.20	2.57	-7.99	-63.84	-55.32	-87.30
Cash EPS ($)	--	2.74	-7.52	-62.71	-53.95	-84.90
Adjusted Book Value ($)	--	--	--	--	30.68	71.76
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-4.01	-6.43	-44.61	-65.53	-56.60
Free Cash Flow per Share ($)	--	-4.01	-6.45	-44.90	-66.54	-59.31

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-166.96	180.15	-351.79	-90.20	-86.63
ROE (%)	--	-48.15	86.92	-2,014.86	-112.39	-91.69
ROA (%)	-42.07	50.55	-62.20	-101.91	-54.06	-64.41
EBIT Margin (%)	-223.36	30.23	-62.66	-3,159.06	-358.51	-1,673.85
Net Margin (%)	-269.42	27.07	-66.23	-3,220.88	-197.16	-1,642.64
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-96.72	-0.06	14.04	-0.87	2.13	4.73
EBIT Growth (%)	-239.03	145.19	70.17	-18.83	33.06	-10.16
Net Profit Growth (%)	-387.97	138.28	69.07	-20.95	32.88	-10.93
EPS Growth (%)	-182.54	1.32	0.87	-0.15	0.37	0.03
Book Value Growth (%)	13.54	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	7.04	-1.67	-0.01	-0.06	-0.18
Price / Book Value	16.14	-5.98	-1.46	-0.02	0.11	0.22
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	2.21	7.10	-1.90	-0.03	0.71	0.85
Close Price ($)	11.48	18.09	13.31	12.83	82.00	394.00
High Price ($)	19.15	18.95	39.50	141.00	423.25	546.25
Low Price ($)	3.92	5.01	6.50	4.98	70.75	295.25
Market Cap ($ Cr)	97.97	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	-1.37	-0.45	-0.58	0.57	0.10
Short term debt to equity ratio	-0.03	-0.28	-0.14	-0.12	0.11	0.01
Current Ratio	1.98	0.82	0.48	0.72	3.74	3.64
Quick Ratio	1.98	0.82	0.40	0.65	3.72	3.64
Interest Coverage	-4.90	9.63	-17.51	-51.24	-611.04	-35.06

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	5.13	1.04	1.15	397.85	63.27	4.85
Asset Turnover	0.16	1.87	0.94	0.03	0.15	0.04
Receivable days	--	4.14	50.41	1,583.38	118.37	20.08
Inventory Days	--	91.73	176.99	232.07	1.07	0.00
Payable days	--	38.69	69.98	216.93	16.40	392.95
Cash Conversion Cycle	--	57.18	157.42	1,598.53	103.05	-372.87

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.